Restart Life Sciences Corp. (FRA:HN30)

Market Cap	2.98M +42.1%
Revenue (ttm)	287.05K
Net Income	-1.05M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,669
Open	0.0430
Previous Close	0.0395
Day's Range	0.0430 - 0.0430
52-Week Range	0.0385 - 0.0785
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba’s Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the development across various product lines, including BrainQ, BrainBalls, and Hol...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HN30

Financial Performance

Financial numbers in CAD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error